• OPEN AN ACCOUNT
Indian Indices
Sensex
72,781.89 -251.89
( -0.34%)
Global Indices
Nasdaq
51,707.15 -164.40
(-0.32%)
Dow Jones
7,828.98 0.74
(0.01%)
Hang Seng
67,780.30 2.78
(0.00%)
Nikkei 225
10,730.66 80.33
(0.75%)
Forex
USD-INR
95.69 -0.76
(-0.79%)
EUR-INR
107.00 -1.04
(-0.96%)
GBP-INR
126.57 -1.05
(-0.82%)
JPY-INR
0.60 -0.01
(-0.89%)

EQUITY - MARKET SCREENER

Natco Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524816
INE987B01026
501.202063
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NATCOPHARM
17.37
15489.42
EPS(TTM)
Face Value()
Div & Yield %
45.47
2
0.58
 

Tiaan Consumer reports standalone net loss of Rs 0.05 crore in the March 2026 quarter
May 22,2026
Net Loss of Tiaan Consumer reported to Rs 0.05 crore in the quarter ended March 2026 as against net loss of Rs 0.01 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 as against Rs 0.03 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 0.14 crore in the year ended March 2026 as against net profit of Rs 0.03 crore during the previous year ended March 2025. Sales rose 90.00% to Rs 0.19 crore in the year ended March 2026 as against Rs 0.10 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales00.03 -100 0.190.10 90
OPM %0-33.33 --68.42-190.00 -
PBDT-0.04-0.01 -300 -0.130.03 PL
PBT-0.04-0.01 -300 -0.130.03 PL
NP-0.05-0.01 -400 -0.140.03 PL